Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life

NCT00625677 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

130

Enrollment

OTHER_GOV

Sponsor class

Conditions

Meningococcal Infections
Pneumococcal Infections

Interventions

BIOLOGICAL: NeisVacC (Meningococcal C conjugate vaccine)
BIOLOGICAL: Menjugate (Meningococcal C conjugate vaccine)

Sponsor

Public Health England

Collaborators

[object Object]
[object Object]